![Montreal CRO MHICC Chooses LifeSphere® Safety to Process Adverse Event Cases as Part of Its Expansion into Post-Market Services](https://www.arisglobal.com/wp-content/themes/arisglobal-theme/assets/img/default-images/generic-teaser-placeholder.jpg)
Montreal Health Innovations Coordinating Center (MHICC), a fast-growing contract research organization, believes LifeSphere’s innovative use of automation and Generative AI is aligned with its pharmacovigilance plans.
Learn More![Newest Version of LifeSphere® Regulatory Platform Allows Organizations to Leverage Latest GenAI Technology](https://www.arisglobal.com/wp-content/themes/arisglobal-theme/assets/img/default-images/generic-teaser-placeholder.jpg)
End-to-end functionality helps cut skyrocketing costs of compliance and removes workflow inefficiencies.
Learn More![Top 5 Global Biotech Company Goes Live with LifeSphere® MultiVigilance and Reporting & Analytics Solution](https://www.arisglobal.com/wp-content/themes/arisglobal-theme/assets/img/default-images/generic-teaser-placeholder.jpg)
The top-tier life sciences company will standardize its Safety operations on the cloud-powered technology platform, LifeSphere, which is propelling life sciences GenAI use cases.
Learn More![Steve Nuckols Joins ArisGlobal as Chief Customer Officer](https://www.arisglobal.com/wp-content/themes/arisglobal-theme/assets/img/default-images/generic-teaser-placeholder.jpg)
Nuckols will apply decades of both life sciences and technology leadership to enhance innovation and customer focus at ArisGlobal
Learn More![New Momentum in Pharma Automation: ArisGlobal’s 2024 Industry Survey Report Highlights Surge in AI-Powered Safety & Regulatory Processes](https://www.arisglobal.com/wp-content/themes/arisglobal-theme/assets/img/default-images/generic-teaser-placeholder.jpg)
The international survey reveals that there is currently a pronounced gap between Life Sciences organizations’ intentions and their actual use of next-generation technologies.
Learn More![Boehringer Ingelheim Transforms Traditional Safety Signal Processing by Leveraging Latest LifeSphere Solutions](https://www.arisglobal.com/wp-content/themes/arisglobal-theme/assets/img/default-images/generic-teaser-placeholder.jpg)
LifeSphere Clarity drives efficiencies and reinvents the way Boehringer Ingelheim’s pharmaceutical operations approach safety signals Boston, Massachusetts, USA –…
Learn More![](https://www.arisglobal.com/wp-content/uploads/2024/04/PhotoIntake-1024x577.jpg)
Advanced Intake™ demonstrates up to 65% efficiency gains in adverse case intake and 90% data extraction accuracy and quality…
Learn More![Second Life Sciences GenAI Council Expands Global Perspective](https://www.arisglobal.com/wp-content/themes/arisglobal-theme/assets/img/default-images/generic-teaser-placeholder.jpg)
Following a successful inaugural gathering in the USA in February, leading global pharmaceutical organizations & AI specialists will meet in Switzerland on May 15th to further fuel adoption of next-generation technologies transforming Life Sciences R&D.
Learn More![Pioneering the Next Frontier: ArisGlobal Unveils Cutting-Edge Safety & Regulatory Product Offerings Powered by Generative AI](https://www.arisglobal.com/wp-content/themes/arisglobal-theme/assets/img/default-images/generic-teaser-placeholder.jpg)
Launched at Breakthrough 2024, ArisGlobal announced Advanced Intake, Real-World Data Subscription, & its Next-Generation LifeSphere Regulatory Platform LONDON, UK – March 20, 2024 – ArisGlobal, an innovative life sciences technology company and creator of LifeSphere®, today announced three cutting-edge product offerings that will transform pharmacovigilance and regulatory operations.
Learn More![](https://www.arisglobal.com/wp-content/uploads/2024/02/Untitled-1.png)
Drug Safety teams across the globe now have access to the…
Learn More